|
PTPN4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62481139653892E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
6.464000E-03 |
| Normal-vs-Stage3 |
2.04281036531029E-14 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
1.589920E-02 |
| Stage1-vs-Stage3 |
3.238000E-01 |
| Stage1-vs-Stage4 |
2.6254999999642E-06 |
| Stage2-vs-Stage3 |
6.144500E-03 |
| Stage2-vs-Stage4 |
9.80710000000329E-05 |
| Stage3-vs-Stage4 |
1.950020E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.71913611019181E-12 |
| Normal-vs-Asian |
3.58740037675886E-10 |
| Caucasian-vs-AfricanAmerican |
7.735200E-01 |
| Caucasian-vs-Asian |
5.858200E-01 |
| AfricanAmerican-vs-Asian |
7.524800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.99200722162641E-16 |
| Normal-vs-Female |
1.62703184258817E-12 |
| Male-vs-Female |
2.796600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
3.97410000463339E-08 |
| Normal-vs-Age(81-100Yrs) |
5.178200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.174000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.941620E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.360800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.478800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.382800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.978000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.57859999999821E-06 |
| Classical-VS-Follicular |
2.15670000000001E-05 |
| Classical-VS-Other |
7.964600E-01 |
| Classical-VS-Normal |
7.7715611723761E-15 |
| Tall-VS-Follicular |
4.96399998883845E-09 |
| Tall-VS-Other |
3.848600E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.640370E-02 |
| Follicular-VS-Normal |
4.002600E-03 |
| Other-VS-Normal |
1.623120E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.44829703785376E-11 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
2.25039999968146E-07 |
|
|
